EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas

Cecilia Dalle Ore, Christina Coleman, Nalin Gupta, Sabine Mueller

Pediatric Neurosurgery · 2023 · 58 (5) · 259-266

DOI: 10.1159/000529099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Neurosurgery, online erschienen am 13.01.2023. Verfasst von Cecilia Dalle Ore und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Brain Stem Neoplasms, Diffuse Intrinsic Pontine Glioma, Glioma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Diffuse intrinsic pontine gliomas (DIPGs) are high-grade gliomas (HGGs) that occur primarily in children, and represent a leading cause of death in pediatric patients with brain tumors with a median overall survival of only 8–11 months. Summary: While these lesions were previously thought to behave similarly to adult HGG, emerging data have demonstrated that DIPG is a biologically distinct entity from adult HGG frequently driven by mutations in the histone genes H3.3 and H3.1 not found in adult glioma. While biopsy of DIPG was historically felt to confer unacceptable risk of morbidity and mortality, multiple studies have demonstrated that stereotactic biopsy of DIPG is safe, allowing not only for improved understanding of DIPG but also forming the basis for protocols for personalized medicine in DIPG. However, current options for personalized medicine in DIPG are limited by the lack of efficacious targeted therapies for the mutations commonly found in DIPG. Multiple treatment modalities including targeted therapies, immunotherapy, convection-enhanced delivery, and focused ultrasound are in various stages of investigation. Key Message: Increasing frequency of biopsy for DIPG has identified distinct driving mutations that may serve as therapeutic targets. Novel treatment modalities are under investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Stem NeoplasmsDiffuse Intrinsic Pontine GliomaGliomaAdultChildHumansImmunotherapyClinical Trials as Topic

Stichwörter der Autor:innen

BiopsyConvection-enhanced deliveryDiffuse intrinsic pontine gliomasImmunotherapy

Autor:innen und Institutionen

  • Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
  • Division of Hematology/Oncology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Québec, Canada.
  • Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Department of Neurology, University of California San Francisco, San Francisco, California, USA.

Zitieren

APA

Dalle Ore, C., Coleman, C., Gupta, N., & Mueller, S. (2023). Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas. Pediatric Neurosurgery, 58(5), 259-266. https://doi.org/10.1159/000529099

Vancouver

Dalle Ore C, Coleman C, Gupta N, Mueller S. Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas. Pediatric Neurosurgery. 2023;58(5):259-266. doi:10.1159/000529099

BibTeX
@article{DalleOre2023,
  author = {Dalle Ore, Cecilia and Coleman, Christina and Gupta, Nalin and Mueller, Sabine},
  title = {Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas},
  journal = {Pediatric Neurosurgery},
  year = {2023},
  volume = {58},
  number = {5},
  pages = {259--266},
  doi = {10.1159/000529099}
}
Kostenlos starten →